| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1086804 | Le Pharmacien Hospitalier et Clinicien | 2012 | 7 Pages |
Abstract
Reviewing the use of dabigatran and rivaroxaban help to define the profile of patients using such medications, to highlight how to use these two anticoagulants, to identify adverse effects. The results show no particular concern with the prescription and administration of these two anticoagulants.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
E. Remetter, F. Raffy, M. Heck, M. Labrude, P.-M. Mertes,